Recap: AcelRx Pharmaceuticals Q2 Earnings

Recap: AcelRx Pharmaceuticals Q2 Earnings

 

AcelRx Pharmaceuticals ACRX reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

AcelRx Pharmaceuticals beat estimated earnings by 14.29%, reporting an EPS of $-0.06 versus an estimate of $-0.07.

Revenue was up $127 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 6.35% increase in the share price the next day.

Here's a look at AcelRx Pharmaceuticals's past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.06   -0.07 -0.08
EPS Actual -0.06 -0.06 -0.07 -0.08
Revenue Estimate 550K 1.85M 1.90M 1.81M
Revenue Actual 442K 2K 1.86M 443K

To track all earnings releases for AcelRx Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings